NurExone Biologic Inc. (id:1873 NRX)
0.750 CAD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 11:41:44 AM)
Exchange closed, opens in 1 day 21 hours
2.74 CAD (2.74%)
11.94 CAD (11.94%)
36.36 CAD (36.36%)
56.25 CAD (56.25%)
141.94 CAD (141.94%)
63.04 CAD (63.04%)
About NurExone Biologic Inc.
Market Capitalization 51.72M
NurExone Biologic Inc., operates as a pharmaceutical technology company. It is developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. The company was founded in 2020 and is based in Toronto, Canada.
| Headquarters (address) |
1 First Canadian Place Toronto M5X 1G5 ON Canada |
| Phone | |
| Website | https://nurexone.com |
| Employees | 8 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | NRX |
| Exchange | Toronto Stock Exchange Venture |
| Currency | CAD |
| 52 week range | 0.260 - 1.19 |
| Market Capitalization | 51.72M |
| P/E trailing | -9.01 |
| P/E forward | -4.06 |
| Price/Book | 19.21 |
| Beta | -0.091 |
| EPS | -0.110 |
| EPS Canada (ID:82, base:722) | 1.84 |